89
Views
3
CrossRef citations to date
0
Altmetric
Original Research

An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch

, , , , , , , & show all
Pages 725-731 | Published online: 10 Mar 2017

Figures & data

Table 1 Demographic characteristics of subjects (n=12)

Table 2 The pharmacokinetic parameters of EE and GSD after a single-dose administration of 30 μg EE/75 μg GSD tablet and 7 days wearing of 1.2 mg EE/1.6 mg GSD study patch (n=12)

Table 3 The comparisons of main pharmacokinetic parameters of EE and GSD between a single-dose administration of 30 μg EE/75 μg GSD tablet and 7 days wearing of 1.2 mg EE/1.6 mg GSD study patch

Figure 1 The mean plasma concentration versus time profiles of (A) EE and (B) GSD after a single-dose administration of tablet.

Abbreviations: EE, ethinylestradiol; GSD, gestodene.
Figure 1 The mean plasma concentration versus time profiles of (A) EE and (B) GSD after a single-dose administration of tablet.

Figure 2 The mean plasma concentration versus time profiles of (A) EE and (B) GSD after a single-dose administration of the study patch.

Abbreviations: EE, ethinylestradiol; GSD, gestodene.
Figure 2 The mean plasma concentration versus time profiles of (A) EE and (B) GSD after a single-dose administration of the study patch.